Literature DB >> 28790674

HOMOLOGOUS BLOOD TRANSFUSION: DO WE HAVE ANY ALTERNATIVES?

S Gokhale1, P S Roy2, Y Ashok3, Jjj Falleiro4.   

Abstract

Homologous blood transfusion, despite numerous and serious transfusion associated hazards, is an important treatment modality. Transmission of infectious agents like HIV, hepatitis viruses, malaria, etc is a distinct possibility notwithstanding careful screening of the blood. Predeposit autologous blood transfusion (PABT) and per operative acute normovolemic haemodilution (ANH) are two comparatively safer, simpler and practical alternatives. Unfortunately, their potential remains unexploited. Earnest motivation efforts at PABT and ANH have paid handsome dividends in our hospital. These have now become very popular amongst surgeons as well as the patients. These techniques can be easily adapted at all hospitals to reduce the demand for homologous blood transfusion. ANH can be safely practised even in hospitals without a blood bank.

Entities:  

Keywords:  Per operative acute normovolemic haemodilution (ANH); Predeposit autologous blood transfusion (PABT); Safety of blood transfusion

Year:  2017        PMID: 28790674      PMCID: PMC5531983          DOI: 10.1016/S0377-1237(17)30126-0

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  5 in total

Review 1.  Autologous transfusion and directed donations: current controversies and future directions.

Authors:  J P AuBuchon
Journal:  Transfus Med Rev       Date:  1989-10

2.  Fluid replacement after blood donation: implications for elderly and autologous blood donors.

Authors:  A Daneshvar
Journal:  Md Med J       Date:  1988-10

Review 3.  Acceptable hematocrit levels in surgical patients.

Authors:  K F Messmer
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

4.  Safety of autologous blood donation prior to elective surgery for a variety of potentially "high-risk" patients.

Authors:  M Mann; H J Sacks; D Goldfinger
Journal:  Transfusion       Date:  1983 May-Jun       Impact factor: 3.157

5.  Safety and effectiveness of predeposit autologous transfusions in preteen and adolescent children.

Authors:  A J Silvergleid
Journal:  JAMA       Date:  1987-06-26       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.